Tris(2,4-dimethyl-5-sulfanatophenyl)phosphine trisodium salt
Product Information
Molecular Formula
C24H26Na3O10PS3
Molecular Weight
670.60
Description
Tris(2,4-dimethyl-5-sulfanatophenyl)phosphine trisodium salt is an imperative compound extensively employed in biomedicine and exhibits an indispensable functionality in the management of diverse maladies and states. As a catalyst in pharmaceutical research and development, this product remarkably facilitates the synthesis of groundbreaking medicaments. Moreover, its scope encompasses the amelioration of neurologic disorders, cardiovascular afflictions, along with select forms of malignancies.
Synonyms
TRIS(4,6-DIMETHYL-3-SULFONATOPHENYL)PHOSPHINE TRISODIUM SALT HYDRATE; MFCD05861614; SC11116; TRIS(2,4-DIMETHYL-5-SULFANATOPHENYL)PHOSPHINE TRISODIUM SALT; sodium 5,5',5''-phosphinetriyltris(2,4-dimethylbenzenesulfonate) hydrate; Tris(2,4-dimethyl-5-sulfanatophenyl)phosphine trisodium salt; Tris(2,4-dimethylphenyl)phosphine-5,5',5""-trisulfonic acid trisodium salt; tris(4,6-dimethyl-3-sulfonatophenyl)-phosphine trisodium salt hydrate
IUPAC Name
trisodium5-bis(2,4-dimethyl-5-sulfonatophenyl)phosphanyl-2,4-dimethylbenzenesulfonatehydrate
SMILES
CC1=CC(=C(C=C1P(C2=CC(=C(C=C2C)C)S(=O)(=O)[O-])C3=CC(=C(C=C3C)C)S(=O)(=O)[O-])S(=O)(=O)[O-])C.O.[Na+].[Na+].[Na+]
InChI
InChI=1S/C24H27O9PS3.3Na.H2O/c1-13-7-16(4)22(35(25,26)27)10-19(13)34(20-11-23(36(28,29)30)17(5)8-14(20)2)21-12-24(37(31,32)33)18(6)9-15(21)3/h7-12H,1-6H3,(H,25,26,27)(H,28,29,30)(H,31,32,33)1H2/q3*+1/p-3
InChI Key
LBWMFZIYNLEWAE-UHFFFAOYSA-K
Safety Information
Hazards
H315 - H319
Precautionary Statement
P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
10
Rotatable Bond Count
3
Exact Mass
670.01188039 g/mol
Monoisotopic Mass
670.01188039 g/mol
Topological Polar Surface Area
198Ų
Heavy Atom Count
41
Formal Charge
0
Complexity
941
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
5
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2019222805-A1 | New synthetic methods using native chemical ligation in flow | 2018-05-22 |
| AU-2019273119-A1 | New synthetic methods using native chemical ligation in flow | 2018-05-22 |
| EP-3797115-A1 | New synthetic methods using native chemical ligation in flow | 2018-05-22 |
| KR-20210029156-A | Novel synthetic method using natural chemical ligation in influent | 2018-05-22 |
| JP-2021525259-A | New flow synthesis method using native chemical ligation | 2018-05-22 |
| WO-2016029216-A2 | Method for producing amidine derivatives | 2014-08-22 |
| EP-3140660-A1 | Enzymatic determination of hba1c | 2014-05-06 |
| EP-3140660-B1 | Enzymatic determination of hba1c | 2014-05-06 |
| EP-3140661-A2 | Enzymatic determination of hba1c | 2014-05-06 |
| EP-3140661-B1 | Enzymatic determination of hba1c | 2014-05-06 |
